Neuroprotective effect of astaxanthin against glutamate-induced cytotoxicity in HT22 cells: Involvement of the Akt/GSK-3β pathway

Neuroscience

Volumn 303, Issue , 2015, Pages 558-568

  Wen, X ^a   Huang, A ^b   Hu, J ^c   Zhong, Z ^c   Liu, Y ^d   Li, Z ^a   Pan, X ^a   Liu, Z ^c,e  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^e Department Hepato Pancreato Biliary Surgery Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation   (China)

Author keywords

Akt; Astaxanthin; GSK 3 ; Nrf2; Oxidative stress

Indexed keywords

APOPTOSIS INDUCING FACTOR; ASTAXANTHIN; CASPASE; CYTOCHROME C; GLUTAMIC ACID; GLYCOGEN SYNTHASE KINASE 3BETA; HEME OXYGENASE 1; LACTATE DEHYDROGENASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; CYTOTOXIN; ENZYME INHIBITOR; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; NEUROPROTECTIVE AGENT; XANTHOPHYLL;

ARTICLE; BIOACCUMULATION; CELL LINE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME RELEASE; FLOW CYTOMETRY; HT22 CELL; MOLECULAR DYNAMICS; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANALYSIS OF VARIANCE; ANIMAL; CELL FRACTIONATION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; DRUG INTERACTION; HIPPOCAMPUS; METABOLISM; MOUSE; NERVE CELL; TRANSFORMED CELL LINE;

ANALYSIS OF VARIANCE; ANIMALS; CASPASES; CELL FRACTIONATION; CELL LINE, TRANSFORMED; CYTOTOXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; GLUTAMIC ACID; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; L-LACTATE DEHYDROGENASE; MICE; NEURONS; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; XANTHOPHYLLS;

EID: 84938150195     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.07.034     Document Type: Article

References (45)

1. Ahmad A.S., Zhuang H., Dore S. Heme oxygenase-1 protects brain from acute excitotoxicity. Neuroscience 2006, 141:1703-1708.
2. Barone E., Di Domenico F., Sultana R., Coccia R., Mancuso C., Perluigi M., Butterfield D.A. Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment. Free Radic Biol Med 2012, 52:2292-2301.
3. Barros M.P., Poppe S.C., Bondan E.F. Neuroprotective properties of the marine carotenoid astaxanthin and omega-3 fatty acids, and perspectives for the natural combination of both in krill oil. Nutrients 2014, 6:1293-1317.
4. Bonda D.J., Wang X., Lee H.G., Smith M.A., Perry G., Zhu X. Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glass. Neurosci Bull 2014, 30:243-252.
5. Burns A. Alzheimer's disease: on the verges of treatment and prevention. Lancet Neurol 2009, 8:4-5.
6. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988, 1:623-634.
7. Choudhary G.S., Al-Harbi S., Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol 2015, 1219:1-9.
8. D'Amelio M., Sheng M., Cecconi F. Caspase-3 in the central nervous system: beyond apoptosis. Trends Neurosci 2012, 35:700-709.
9. de Vries H.E., Witte M., Hondius D., Rozemuller A.J., Drukarch B., Hoozemans J., van Horssen J. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?. Free Radic Biol Med 2008, 45:1375-1383.
10. Espada S., Rojo A.I., Salinas M., Cuadrado A. The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK-3beta: connecting neurotransmission with neuroprotection. J Neurochem 2009, 110:1107-1119.
11. Garza J.C., Guo M., Zhang W., Lu X.Y. Leptin restores adult hippocampal neurogenesis in a chronic unpredictable stress model of depression and reverses glucocorticoid-induced inhibition of GSK-3beta/beta-catenin signaling. Mol Psychiatry 2012, 17:790-808.
12. Gupta S. Molecular steps of death receptor and mitochondrial pathways of apoptosis. Life Sci 2001, 69:2957-2964.
13. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
14. Hussein G., Sankawa U., Goto H., Matsumoto K., Watanabe H. Astaxanthin, a carotenoid with potential in human health and nutrition. J Nat Prod 2006, 69:443-449.
15. Jain A.K., Jaiswal A.K. GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J Biol Chem 2007, 282:16502-16510.
16. Kanninen K., Malm T.M., Jyrkkanen H.K., Goldsteins G., Keksa-Goldsteine V., Tanila H., Yamamoto M., Yla-Herttuala S., Levonen A.L., Koistinaho J. Nuclear factor erythroid 2-related factor 2 protects against beta amyloid. Mol Cell Neurosci 2008, 39:302-313.
17. Kilic U., Kilic E., Tuzcu Z., Tuzcu M., Ozercan I.H., Yilmaz O., Sahin F., Sahin K. Melatonin suppresses cisplatin-induced nephrotoxicity via activation of Nrf-2/HO-1 pathway. Nutr Metab (Lond) 2013, 10:7.
18. Kuo K.L., Lin W.C., Ho I.L., Chang H.C., Lee P.Y., Chung Y.T., Hsieh J.T., Pu Y.S., Shi C.S., Huang K.H. 2-Methoxyestradiol induces mitotic arrest, apoptosis, and synergistic cytotoxicity with arsenic trioxide in human urothelial carcinoma cells. PLoS One 2013, 8:e68703.
19. Lee H.G., Li M.H., Joung E.J., Na H.K., Cha Y.N., Surh Y.J. Nrf2-Mediated heme oxygenase-1 upregulation as adaptive survival response to glucose deprivation-induced apoptosis in HepG2 cells. Antioxid Redox Signal 2010, 13:1639-1648.
20. Leroy K., Yilmaz Z., Brion J.P. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathol Appl Neurobiol 2007, 33:43-55.
21. Lobner D. Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis?. J Neurosci Methods 2000, 96:147-152.
22. Maher P., Davis J.B. The role of monoamine metabolism in oxidative glutamate toxicity. J Neurosci 1996, 16:6394-6401.
23. Mattson M.P. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 2000, 1:120-129.
24. Morley J.E., Armbrecht H.J., Farr S.A., Kumar V.B. The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer's disease. Biochim Biophys Acta 2012, 1822:650-656.
25. Muzio M., Stockwell B.R., Stennicke H.R., Salvesen G.S., Dixit V.M. An induced proximity model for caspase-8 activation. J Biol Chem 1998, 273:2926-2930.
26. Niture S.K., Khatri R., Jaiswal A.K. Regulation of Nrf2-an update. Free Radic Biol Med 2014, 66:36-44.
27. Niwano T., Terazawa S., Nakajima H., Wakabayashi Y., Imokawa G. Astaxanthin and withaferin A block paracrine cytokine interactions between UVB-exposed human keratinocytes and human melanocytes via the attenuation of endothelin-1 secretion and its downstream intracellular signaling. Cytokine 2015, 73:184-197.
28. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., Jones P.K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C.S., Petersen R.B., Smith M.A. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001, 60:759-767.
29. Orrenius S., Gogvadze V., Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 2007, 47:143-183.
30. Pap M., Cooper G.M. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J Biol Chem 1998, 273:19929-19932.
31. Papasozomenos S., Shanavas A. Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3 beta but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of tau: implications for Alzheimer's disease. Proc Natl Acad Sci U S A 2002, 99:1140-1145.
32. Peng L., Zhang X., Cui X., Zhu D., Wu J., Sun D., Yue Q., Li Z., Liu H., Li G., Zhang J., Xu H., Liu F., Qin C., Li M., Sun J. Paliperidone protects SK-N-SH cells against glutamate toxicity via Akt1/GSK3beta signaling pathway. Schizophr Res 2014, 157:120-127.
33. Perluigi M., Sultana R., Cenini G., Di Domenico F., Memo M., Pierce W.M., Coccia R., Butterfield D.A. Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: role of lipid peroxidation in Alzheimer's disease pathogenesis. Proteomics Clin Appl 2009, 3:682-693.
34. Rojo A.I., Sagarra M.R., Cuadrado A. GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress. J Neurochem 2008, 105:192-202.
35. Salazar M., Rojo A.I., Velasco D., de Sagarra R.M., Cuadrado A. Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2. J Biol Chem 2006, 281:14841-14851.
36. Saw C.L., Yang A.Y., Guo Y., Kong A.N. Astaxanthin and omega-3 fatty acids individually and in combination protect against oxidative stress via the Nrf2-ARE pathway. Food Chem Toxicol 2013, 62:869-875.
37. Scapagnini G., Vasto S., Abraham N.G., Caruso C., Zella D., Fabio G. Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol 2011, 44:192-201.
38. Tayler H., Fraser T., Miners J.S., Kehoe P.G., Love S. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-beta. J Alzheimers Dis 2010, 22:1363-1373.
39. von Otter M., Landgren S., Nilsson S., Zetterberg M., Celojevic D., Bergstrom P., Minthon L., Bogdanovic N., Andreasen N., Gustafson D.R., Skoog I., Wallin A., Tasa G., Blennow K., Nilsson M., Hammarsten O., Zetterberg H. Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract. Mech Ageing Dev 2010, 131:105-110.
40. Wang H.Q., Sun X.B., Xu Y.X., Zhao H., Zhu Q.Y., Zhu C.Q. Astaxanthin upregulates heme oxygenase-1 expression through ERK1/2 pathway and its protective effect against beta-amyloid-induced cytotoxicity in SH-SY5Y cells. Brain Res 2010, 1360:159-167.
41. Wang X., Wang W., Li L., Perry G., Lee H.G., Zhu X. Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. Biochim Biophys Acta 2014, 1842:1240-1247.
42. Wu Q., Zhang X.S., Wang H.D., Zhang X., Yu Q., Li W., Zhou M.L., Wang X.L. Astaxanthin activates nuclear factor erythroid-related factor 2 and the antioxidant responsive element (Nrf2-ARE) pathway in the brain after subarachnoid hemorrhage in rats and attenuates early brain injury. Mar Drugs 2014, 12:6125-6141.
43. Wu W., Wang X., Xiang Q., Meng X., Peng Y., Du N., Liu Z., Sun Q., Wang C., Liu X. Astaxanthin alleviates brain aging in rats by attenuating oxidative stress and increasing BDNF levels. Food Funct 2014, 5:158-166.
44. Zhou Y., Xie N., Li L., Zou Y., Zhang X., Dong M. Puerarin alleviates cognitive impairment and oxidative stress in APP/PS1 transgenic mice. Int J Neuropsychopharmacol 2014, 17:635-644.
45. Zou Y., Hong B., Fan L., Zhou L., Liu Y., Wu Q., Zhang X., Dong M. Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: involvement of the GSK-3beta/Nrf2 signaling pathway. Free Radic Res 2013, 47:55-63.